LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 119

Search options

  1. Article ; Online: Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF- α Inhibitor Therapy: A Single Center Experience.

    Usui, Joichi / Salvatore, Steven P / Yamagata, Kunihiro / Seshan, Surya V

    Kidney360

    2023  Volume 4, Issue 3, Page(s) 363–373

    MeSH term(s) Tumor Necrosis Factor Inhibitors ; Infliximab/adverse effects ; Adalimumab/adverse effects
    Chemical Substances Tumor Necrosis Factor Inhibitors ; Infliximab (B72HH48FLU) ; Adalimumab (FYS6T7F842)
    Language English
    Publishing date 2023-01-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2641-7650
    ISSN (online) 2641-7650
    DOI 10.34067/KID.0000000000000063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: IX. Impaired drug metabolism].

    Usui, Joichi

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

    2015  Volume 104, Issue 5, Page(s) 967–974

    MeSH term(s) Animals ; General Practitioners ; Humans ; Japan ; Kidney/drug effects ; Kidney/physiopathology ; Kidney Diseases/drug therapy ; Kidney Diseases/metabolism ; Metabolic Diseases/drug therapy ; Pharmaceutical Preparations
    Chemical Substances Pharmaceutical Preparations
    Language Japanese
    Publishing date 2015-10-25
    Publishing country Japan
    Document type Journal Article ; Review
    ZDB-ID 952816-7
    ISSN 1883-2083 ; 0021-5384
    ISSN (online) 1883-2083
    ISSN 0021-5384
    DOI 10.2169/naika.104.967
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor-Like1-Positive Membranous Nephropathy.

    Takahashi-Kobayashi, Mayumi / Usui, Joichi / Kawanishi, Kunio / Saito, Chie / Ebihara, Itaru / Yamagata, Kunihiro

    Kidney international reports

    2023  Volume 8, Issue 8, Page(s) 1698–1699

    Language English
    Publishing date 2023-06-08
    Publishing country United States
    Document type Journal Article
    ISSN 2468-0249
    ISSN (online) 2468-0249
    DOI 10.1016/j.ekir.2023.05.032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy.

    Nakajima, Shuhei / Nagai, Kei / Sakata, Akiko / Usui, Joichi / Yamagata, Kunihiro / Ueda, Atsushi

    Case reports in nephrology

    2023  Volume 2023, Page(s) 4926000

    Abstract: Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases ...

    Abstract Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases had a history of nephrotic syndrome. A 76 year-old Japanese man visited a nephrologist because of incident nephrotic syndrome. He had previously experienced three episodes of nephrotic syndrome, the last one 13 years ago, and had been diagnosed with membranous nephropathy by renal biopsy. Apart from these previous episodes, he also suffered from systemic lymphadenopathy, anemia, elevated C-reactive protein, polyclonal hypergammopathy, and elevated interleukin (IL)-6. An inguinal lymph node biopsy revealed CD138-positive plasma cells in the interfollicular region. Based on these findings, MCD was diagnosed. Renal biopsy indicated primary membranous nephropathy with spike lesions and bubbling in the basement membranes and deposition of immunoglobulin (Ig) G, IgA, IgM, and phospholipase A2 receptor along the glomerular basement membrane. Corticosteroid monotherapy successfully reduced the edema, proteinuria, and IL-6, but hypoalbuminemia was not sufficiently improved due to castleman's disease and remission of the nephrotic syndrome was not achieved. Later, tocilizumab was administered for remission induction in another facility. To the best of our knowledge, this represents the first report of Castleman's disease with previously diagnosed membranous nephropathy. This case does not provide a causal mechanism for the pathophysiology, but it may be worth suggesting possible involvement of MCD as a trigger for recurrence of membranous nephropathy.
    Language English
    Publishing date 2023-02-22
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2627652-5
    ISSN 2090-665X ; 2090-6641
    ISSN (online) 2090-665X
    ISSN 2090-6641
    DOI 10.1155/2023/4926000
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: In Silico

    Takahashi-Kobayashi, Mayumi / Usui, Joichi / Kawanishi, Kunio / Yamagata, Kunihiro

    Journal of the American Society of Nephrology : JASN

    2022  Volume 33, Issue 12, Page(s) 2321–2322

    MeSH term(s) Humans ; Glomerulonephritis, Membranous ; Receptors, Phospholipase A2 ; Autoantigens
    Chemical Substances Receptors, Phospholipase A2 ; Autoantigens
    Language English
    Publishing date 2022-09-29
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1085942-1
    ISSN 1533-3450 ; 1046-6673
    ISSN (online) 1533-3450
    ISSN 1046-6673
    DOI 10.1681/ASN.2022070832
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Increased intrarenal post-glomerular blood flow is a key condition for the development of calcineurin inhibitor-induced renal tubular acidosis in kidney transplant recipients.

    Kaneko, Shuzo / Usui, Joichi / Takahashi, Kazuhiro / Oda, Tatsuya / Yamagata, Kunihiro

    Clinical transplantation

    2022  Volume 36, Issue 6, Page(s) e14648

    Abstract: Background: Hyperchloremic metabolic acidosis (HCMA) from renal tubular acidosis (RTA) is common in kidney transplant (KT) recipients. Calcineurin inhibitors (CNIs) are a potential cause of RTA, and whether HCMA is a determinant of poor graft prognosis ... ...

    Abstract Background: Hyperchloremic metabolic acidosis (HCMA) from renal tubular acidosis (RTA) is common in kidney transplant (KT) recipients. Calcineurin inhibitors (CNIs) are a potential cause of RTA, and whether HCMA is a determinant of poor graft prognosis is controversial.
    Methods: The subjects were living-donor KT recipients (LDKTRs, n = 47) and matched donors (n = 43). All cases of rejection, extrarenal causes, and respiratory disorders were excluded. HCMA was defined as having a [Na+]-[Cl
    Results: The HCMA incidence in the 3-m post-KT LDKTR group was higher than that of the donors (51.0% vs. 6.9%, p < 0.001, adjusted odds ratio: 6.7-15.7). Among adjusted factors, the most dominant HCMA contributor was low hemoglobin concentration (Hb ≤ 12 g/dl). Compared to non-HCMA cases, HCMA patients had low FF and low post-VR (p = 0.008, 0.003, respectively) suggesting increased intrarenal post-glomerular blood flow. The high pathological score of alternative arteriolar hyalinosis (aah) ≥2 was a significant HCMA risk. The tacrolimus trough level was not high in HCMA but was significantly high in HCMA in the low post-VR setting (p = 0.002).
    Conclusion: Among LDKTRs, low hemoglobin level is an important contributor to the manifestation of HCMA in the induction period, and increased intrarenal post-glomerular blood flow is a key condition for the development of CNI-induced RTA.
    MeSH term(s) Acidosis, Renal Tubular/epidemiology ; Acidosis, Renal Tubular/etiology ; Acidosis, Renal Tubular/metabolism ; Calcineurin Inhibitors/adverse effects ; Glomerular Filtration Rate ; Graft Rejection ; Hemoglobins ; Humans ; Immunosuppressive Agents ; Kidney Diseases/complications ; Kidney Transplantation/adverse effects ; Transplant Recipients
    Chemical Substances Calcineurin Inhibitors ; Hemoglobins ; Immunosuppressive Agents
    Language English
    Publishing date 2022-03-20
    Publishing country Denmark
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639001-8
    ISSN 1399-0012 ; 0902-0063
    ISSN (online) 1399-0012
    ISSN 0902-0063
    DOI 10.1111/ctr.14648
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Cardiorenal damages in mice at early phase after intervention induced by angiotensin II, nephrectomy, and salt intake.

    Muromachi, Naoto / Ishida, Junji / Noguchi, Kazuyuki / Akiyama, Tomoki / Maruhashi, Syunsuke / Motomura, Kaori / Usui, Joichi / Yamagata, Kunihiro / Fukamizu, Akiyoshi

    Experimental animals

    2023  Volume 73, Issue 1, Page(s) 11–19

    Abstract: The interconnection of heart performance and kidney function plays an important role for maintaining homeostasis through a variety of physiological crosstalk between these organs. It has been suggested that acute or chronic dysfunction in one organ ... ...

    Abstract The interconnection of heart performance and kidney function plays an important role for maintaining homeostasis through a variety of physiological crosstalk between these organs. It has been suggested that acute or chronic dysfunction in one organ causes dysregulation in another one, like patients with cardiorenal syndrome. Despite its growing recognition as global health issues, still little is known on pathophysiological evaluation between the two organs. Previously, we established a preclinical murine model with cardiac hypertrophy and fibrosis, and impaired kidney function with renal enlargement and increased urinary albumin levels induced by co-treatment with vasopressor angiotensin II (A), unilateral nephrectomy (N), and salt loading (S) (defined as ANS treatment) for 4 weeks. However, how both tissues, heart and kidney, are initially affected by ANS treatment during the progression of tissue damages remains to be determined. Here, at one week after ANS treatment, we found that cardiac function in ANS-treated mice (ANS mice) are sustained despite hypertrophy. On the other hand, kidney dysfunction is evident in ANS mice, associated with high blood pressure, enlarged glomeruli, increased levels of urinary albumin and urinary neutrophil gelatinase-associated lipocalin, and reduced creatinine clearance. Our results suggest that cardiorenal tissues become damaged at one week after ANS treatment and that ANS mice are useful as a model causing transition from early to late-stage damages of cardiorenal tissues.
    MeSH term(s) Humans ; Mice ; Animals ; Angiotensin II ; Sodium Chloride, Dietary/adverse effects ; Nephrectomy/adverse effects ; Kidney ; Cardio-Renal Syndrome/drug therapy ; Albumins
    Chemical Substances Angiotensin II (11128-99-7) ; Sodium Chloride, Dietary ; Albumins
    Language English
    Publishing date 2023-07-18
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 2088228-2
    ISSN 1881-7122 ; 1341-1357 ; 0007-5124
    ISSN (online) 1881-7122
    ISSN 1341-1357 ; 0007-5124
    DOI 10.1538/expanim.23-0071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis.

    Takahashi-Kobayashi, Mayumi / Sada, Ken-Ei / Kawashima, Soko / Miyawaki, Yoshia / Nakazawa, Daigo / Furuichi, Kengo / Okada, Hirokazu / Narita, Ichiei / Usui, Joichi

    Clinical and experimental nephrology

    2023  Volume 28, Issue 4, Page(s) 316–324

    Abstract: Background: The guidelines in Japan for the treatment of rapidly progressive glomerulonephritis (RPGN) have been revised; the latest update was released in 2020. We investigated the actual usage of the new guidelines in Japan.: Methods: We ... ...

    Abstract Background: The guidelines in Japan for the treatment of rapidly progressive glomerulonephritis (RPGN) have been revised; the latest update was released in 2020. We investigated the actual usage of the new guidelines in Japan.
    Methods: We distributed a survey electronically to board-certified nephrologists throughout Japan from December 15, 2021 to January 31, 2022. The survey focused on anti-neutrophil cytoplasmic antibody (ANCA)-associated RPGN and anti-glomerular basement membrane (GBM)-antibody RPGN, plus the treatment strategies and infection-prevention measures used.
    Results: The survey was completed by 155 certified nephrologists from medical facilities across Japan. Their responses regarding treatment procedures revealed that ANCA-associated RPGN was treated with immunosuppressants and/or biologics by 58.1% of the survey respondents, and with plasma exchange (PE) in combination with corticosteroids by 21.3%. Regarding anti-GBM-antibody RPGN, 78.1% of the respondents used corticosteroids in combination with PE (63.2%), cyclophosphamide (CY) (23.9%), or rituximab (RTX) (8.4%), suggesting a discrepancy between clinical practice and the actual use of the guidelines. Trimethoprim-sulfamethoxazole was prescribed as prophylaxis by 94.8% of the respondents, reflecting the widespread recognition of the need to prevent infectious disease in patients with RPGN.
    Conclusions: The survey responses revealed how Japan's new RPGN guidelines are used in actual clinical practice. Our findings will contribute to the guidelines' dissemination and implementation.
    MeSH term(s) Humans ; Adrenal Cortex Hormones ; Antibodies, Antineutrophil Cytoplasmic ; Glomerulonephritis/drug therapy ; Japan ; Nephritis ; Nephrologists ; Surveys and Questionnaires ; Practice Guidelines as Topic
    Chemical Substances Adrenal Cortex Hormones ; Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2023-12-28
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1338768-6
    ISSN 1437-7799 ; 1342-1751
    ISSN (online) 1437-7799
    ISSN 1342-1751
    DOI 10.1007/s10157-023-02441-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: [Epidemiology, prevention and treatment of drug-induced kidney injury].

    Kaneko, Shuzo / Usui, Joichi / Yamagata, Kunihiro

    Nihon Jinzo Gakkai shi

    2019  Volume 58, Issue 7, Page(s) 1055–1058

    MeSH term(s) Acute Kidney Injury/chemically induced ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/prevention & control ; Acute Kidney Injury/therapy ; Humans ; Japan/epidemiology
    Language Japanese
    Publishing date 2019-01-08
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1195538-7
    ISSN 0385-2385
    ISSN 0385-2385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Renal Hemodynamic and Functional Changes in ADPKD Patients.

    Ishii, Ryota / Kai, Hirayasu / Nakajima, Kentaro / Harada, Takuya / Akiyama, Tomoki / Okada, Eri / Tsunoda, Ryoya / Usui, Toshiaki / Mase, Kaori / Morito, Naoki / Saito, Chie / Usui, Joichi / Yamagata, Kunihiro

    Kidney360

    2024  

    Abstract: Background: Although the mechanisms underlying cyst enlargement in autosomal dominant polycystic kidney disease (ADPKD) are becoming clearer, those of renal dysfunction are not fully understood. In particular, total kidney volume (TKV) and renal ... ...

    Abstract Background: Although the mechanisms underlying cyst enlargement in autosomal dominant polycystic kidney disease (ADPKD) are becoming clearer, those of renal dysfunction are not fully understood. In particular, total kidney volume (TKV) and renal function do not always correspond. To elucidate this discrepancy, we studied in detail glomerular hemodynamic changes during ADPKD progression.
    Methods: Sixty-one ADPKD patients with baseline height-adjusted TKV (Ht-TKV) of 933±537 ml/m and serum creatinine of 1.16±0.62 mg/dl were followed for 2 years. Glomerular filtration rate (GFR) and renal plasma flow (RPF) slopes were calculated from inulin clearance (Cin) and para-aminohippuric acid (PAH) clearance (CPAH), respectively, while glomerular hydrostatic pressure (Pglo), afferent resistance (RA), and efferent resistance (RE) were estimated using the Gomez formulae. Each parameter was compared with baseline Ht-TKV. Patients were also subclassified into 1A-1B and 1C-1E groups according to the baseline Mayo imaging classification (MIC), and then compared with respect to GFR, RPF, FF and glomerular hemodynamics.
    Results: After 2 years, Ht-TKV increased (933±537 to 1000±648 ml/m, P<0.01), GFR decreased (66.7±30 to 57.3±30.1 ml/min/1.73m2, P<0.001), and RPF decreased (390±215 to 339±190 ml/min/1.73m2, P<0.05). Further, Pglo was decreased and RA was increased. Baseline Ht-TKV was inversely correlated with GFR (r=-0.29, P<0.05), but there was no association between baseline Ht-TKV and RPF, Pglo, RA, or RE annual changes. However, despite an increase in RE in 1A-1B group, RE was decreased in 1C-1E group. As a result, RE slope was significantly lower in 1C-1E group than 1A-1B group over time (-83(-309 to 102) to 164(-34 to 343) dyne・s・cm-5, P<0.01).
    Conclusions: This is the first report examining yearly changes of GFR (Inulin), RPF (PAH), and renal microcirculation parameters in ADPKD patients. Our results demonstrate that GFR reduction was caused by RA increase, which was faster due to RE decrease in subjects with faster Ht-TKV increase.
    Language English
    Publishing date 2024-03-21
    Publishing country United States
    Document type Journal Article
    ISSN 2641-7650
    ISSN (online) 2641-7650
    DOI 10.34067/KID.0000000000000412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top